Articles
Volume 9 Supplement 2
Controversies in breast cancer
Short communications
Controversies in Breast Cancer 2007
Edinburgh, UK
3-4 September 2007
Edited by William R Miller, Lesley J Fallowfield, Mitch Dowsett, Richard J Santen, James N Ingle
The Symposium and supplement were supported by unrestricted educational grants from AstraZeneca, Novartis, Pfizer and Roche
|
Preface
Preface: controversies in breast cancer William R Miller Breast Cancer Research 2007, 9(Suppl 2):S1 (20 December 2007) |
|
Section introduction
Psychosocial controversies in breast cancer Lesley Fallowfield Breast Cancer Research 2007, 9(Suppl 2):S2 (20 December 2007) |
|
Short communication
The case for user involvement in research: the research priorities of cancer patients David NM Wright, Jessica L Corner, Jane B Hopkinson, Claire L Foster Breast Cancer Research 2007, 9(Suppl 2):S3 (20 December 2007) |
|
Short communication
Why patient representation might harm science? Jim Cassidy Breast Cancer Research 2007, 9(Suppl 2):S4 (20 December 2007) |
|
Short communication
Emma L Pennery Breast Cancer Research 2007, 9(Suppl 2):S5 (20 December 2007) |
|
Short communication
Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours? Jim Cassidy Breast Cancer Research 2007, 9(Suppl 2):S6 (20 December 2007) |
|
Short communication
Lesley Fallowfield Breast Cancer Research 2007, 9(Suppl 2):S7 (20 December 2007) |
|
Short communication
Decision making in local therapy for breast cancer Monica Morrow Breast Cancer Research 2007, 9(Suppl 2):S8 (20 December 2007) |
|
Short communication
Benefits of complementary therapies Caroline Hoffman Breast Cancer Research 2007, 9(Suppl 2):S9 (20 December 2007) |
|
Short communication
The dangers of complementary therapy Mike Baum Breast Cancer Research 2007, 9(Suppl 2):S10 (20 December 2007) |
|
Section introduction
Introduction to sessions on Personalising treatment Mitch Dowsett, William R Miller Breast Cancer Research 2007, 9(Suppl 2):S11 (20 December 2007) |
|
Short communication
Personalized surgical treatment of breast cancer Monica Morrow Breast Cancer Research 2007, 9(Suppl 2):S12 (20 December 2007) |
|
Short communication
Short-term presurgical treatment for all? Mitch Dowsett, Janine Salter, Margaret Hills, Simone Detre, Roger A'Hern, Ian E Smith Breast Cancer Research 2007, 9(Suppl 2):S13 (20 December 2007) |
|
Short communication
Adjuvant treatment: the contribution of expression microarrays Per Lønning, Ranjan Chrisanthar, Vidar Staalesen, Stian Knappskog, Johan Lillehaug Breast Cancer Research 2007, 9(Suppl 2):S14 (20 December 2007) |
|
Short communication
Current and future choices in endocrine therapy Matthew Ellis Breast Cancer Research 2007, 9(Suppl 2):S15 (20 December 2007) |
|
Section introduction
Introduction: challenging established dogma Richard J Santen Breast Cancer Research 2007, 9(Suppl 2):S16 (20 December 2007) |
|
Short communication
Does presurgical treatment destroy important prognostic information J Michael Dixon Breast Cancer Research 2007, 9(Suppl 2):S17 (20 December 2007) |
|
Short communication
Surrogates are just surrogates, but helpful just the same Carol Fabian Breast Cancer Research 2007, 9(Suppl 2):S18 (20 December 2007) |
|
Short communication
Do classical oestrogen markers predict for clinical response to endocrine therapy? William R Miller Breast Cancer Research 2007, 9(Suppl 2):S19 (20 December 2007) |
|
Short communication
The origins of oestrogen receptor negative breast cancer D Craig Allred Breast Cancer Research 2007, 9(Suppl 2):S20 (20 December 2007) |
